ArticleBlood cancer journal2025

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.

Christina Rautenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.